Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Flea and Tick Products Market Research Report 2026-2031 - Rising Pet Ownership and Parasite Prevention Awareness Drive Growth

globenewswire.com
ELAN Elanco is mentioned as a company in the flea and tick product market, which is projected to grow significantly. The article discusses market trends and product categories relevant to Elanco's business, but provides no specific sentiment towards the company itself. ZTS Zoetis is listed as a company in the flea and tick product market, which is experiencing growth. The article outlines market drivers and product trends, but does not offer specific sentiment or performance indicators for Zoetis. MRK Merck Animal Health is identified as a player in the growing flea and tick product market. The article discusses industry trends and growth forecasts, but does not provide specific sentiment or commentary on Merck Animal Health's performance. CENT Central Garden & Pet is mentioned as a company within the flea and tick product market, which is expected to grow. The article details market dynamics and product categories, but offers no specific sentiment towards Central Garden & Pet.

Global Flea and Tick Products Market Research Report 2026-2031 - Rising Pet Ownership and Parasite Prevention Awareness Drive Growth Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Flea and Tick Product - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.

The global flea and tick product market is projected to grow from USD 7.40 billion in 2025 to USD 8.09 billion in 2026 before reaching USD 12.63 billion by 2031. This represents a compound annual growth rate of 9.32% from 2026 to 2031, supported by rising pet ownership, greater awareness of vector-borne diseases, and growing demand for convenient, long-lasting parasite prevention products.

Flea- and Tick-Borne Diseases Drive Preventive Care

The increasing prevalence of flea- and tick-borne diseases is strengthening demand for year-round pet parasite prevention. The Centers for Disease Control and Prevention recorded 89,000 Lyme disease cases in 2023, 68.5% above the 2017-2019 baseline. Veterinary laboratories have also reported Ehrlichia and Anaplasma positivity rates exceeding 5% in 15 U.S. states. In Asia, rising detection of Babesia gibsoni among dogs in Japan and South Korea is expanding the need for reliable preventive treatments.

The financial impact of infection is also influencing purchasing decisions. Treatment can cost between USD 500 and USD 2,000 per canine case, compared with annual preventive expenses of approximately USD 300. As a result, more pet owners are adopting continuous flea and tick protection as a cost-effective approach to animal health.

Pet Adoption and Humanization Support Premium Product Demand

Higher pet ownership and increased spending on companion animal wellness are accelerating flea and tick product market growth. The American Pet Products Association reported that 66% of U.S. households owned a pet in 2024, an increase of 10 percentage points from 2019. China had approximately 120.75 million companion animals in 2023, while India's pet sector is projected to reach USD 24.8 billion by 2032.

Pet owners are increasingly choosing premium combination products that address fleas, ticks, heartworms, and intestinal parasites in a single monthly dose. Flavored oral chewables are gaining particular traction due to their convenience, palatability, and reduced risk of dermal irritation. Expanding insurance coverage for preventive veterinary care in markets such as the United Kingdom and Scandinavia is also helping improve treatment compliance.

Oral Flea and Tick Treatments Record the Fastest Growth

Oral chews and tablets are forecast to expand at a 10.49% CAGR, making them the fastest-growing product category. Demand is being supported by monthly combination treatments and longer-duration solutions that reduce the need for frequent administration. Beef, chicken, and fish formulations tailored to different animal sizes are also encouraging investment in product development.

Spot-on topical treatments accounted for 48.42% of market revenue in 2025, retaining the largest share. However, their position is gradually weakening as consumers shift toward mess-free systemic treatments. Flea and tick collars offer protection lasting up to eight months but face greater environmental scrutiny related to chemical residues. Sprays, powders, shampoos, and dips collectively represent less than 10% of the market and are used primarily in shelters, kennels, and specialized care settings.

Safety Concerns Encourage Greater Veterinary Oversight

Safety concerns surrounding chemical treatments remain a market restraint. The U.S. Food and Drug Administration updated its isoxazoline alert in 2024, citing neurological events in a small number of pets and recommending caution for animals with seizure histories. European regulators have maintained a positive benefit-risk assessment for major treatments while emphasizing closer veterinary guidance. These concerns are prompting some consumers to consider botanical sprays and other alternative products.

Additional market influences include growing awareness of zoonotic risks, the expansion of telehealth and e-commerce subscription services, and emerging acaricide resistance among tick populations. Subscription platforms are particularly important because they automate repeat purchases and may improve adherence to recommended treatment schedules.

Regional Flea and Tick Product Market Outlook

North America generated 41.98% of global revenue in 2025, supported by annual preventive spending of approximately USD 200 to USD 400 per pet and an established veterinary clinic network. The continued spread of disease-carrying tick species into southern Canadian provinces is expected to sustain regional demand.

Europe represented approximately 28% of the market, although evolving environmental regulations could restrict the use of selected active ingredients. Asia-Pacific is forecast to record the fastest regional CAGR of 10.54% through 2031, driven by China's expanding urban pet population and rapid growth in India's companion animal economy. South America, the Middle East, and Africa also offer long-term opportunities as veterinary infrastructure improves and regional approval systems become more streamlined.

Overall, the flea and tick product market is expected to benefit from sustained investment in combination therapies, extended-duration protection, flavored oral formulations, and digital distribution. Products that balance efficacy, convenience, safety, and environmental responsibility are likely to shape market growth through 2031.

Key Topics Covered

1 Introduction

1.1 Study Assumptions & Market Definition

1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

4.1 Market Overview

4.2 Market Drivers

4.2.1 High prevalence of flea- & tick-borne diseases in pets

4.2.2 Increasing pet adoption & humanization trend

4.2.3 Growing owner awareness of zoonotic risks

4.2.4 Tele-health & e-commerce subscriptions expand access

4.2.5 Regulatory push for long-duration combo formulations

4.2.6 Climate-driven expansion of tick habitats

4.3 Market Restraints

4.3.1 Adverse-event & safety concerns with chemicals

4.3.2 Counterfeit & sub-standard products in grey market

4.3.3 Emerging acaricide resistance in tick populations

4.3.4 Tightening EU eco-toxicology regulations on actives

4.4 Value / Supply-Chain Analysis

4.5 Regulatory Landscape

4.6 Technological Outlook

4.7 Porter's Five Forces Analysis

4.7.1 Threat of New Entrants

4.7.2 Bargaining Power of Buyers

4.7.3 Bargaining Power of Suppliers

4.7.4 Threat of Substitutes

4.7.5 Intensity of Rivalry

5 Market Size & Growth Forecasts (Value, USD)

5.1 By Product Form

5.1.1 Oral Chews and Tablets

5.1.2 Spot-On Topicals

5.1.3 Sprays & Mists

5.1.4 Collars

5.1.5 Shampoos & Dips

5.1.6 Powders & Dusts

5.1.7 Others

5.2 By Animal

5.2.1 Dogs

5.2.2 Cats

5.2.3 Other Animals

5.3 By Distribution Channel

5.3.1 Veterinary Clinics

5.3.2 Retail Pet Stores & Pharmacies

5.3.3 E-commerce and Subscription Platforms

5.3.4 Others

5.4 By Geography

5.4.1 North America

5.4.1.1 United States

5.4.1.2 Canada

5.4.1.3 Mexico

5.4.2 Europe

5.4.2.1 Germany

5.4.2.2 United Kingdom

5.4.2.3 France

5.4.2.4 Italy

5.4.2.5 Spain

5.4.2.6 Rest of Europe

5.4.3 Asia-Pacific

5.4.3.1 China

5.4.3.2 Japan

5.4.3.3 India

5.4.3.4 Australia

5.4.3.5 South Korea

5.4.3.6 Rest of Asia-Pacific

5.4.4 Middle East and Africa

5.4.4.1 GCC

5.4.4.2 South Africa

5.4.4.3 Rest of Middle East and Africa

5.4.5 South America

5.4.5.1 Brazil

5.4.5.2 Argentina

5.4.5.3 Rest of South America

6 Competitive Landscape

6.1 Market Concentration

6.2 Market Share Analysis

6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)

6.3.1 Bayer AG (Seresto)

6.3.2 Bimeda Animal Health

6.3.3 Boehringer Ingelheim

6.3.4 Central Garden & Pet

6.3.5 Ceva Sante Animale

6.3.6 Dechra Pharmaceuticals

6.3.7 Ecto Development

6.3.8 Elanco

6.3.9 Hartz Mountain

6.3.10 Laboratoires Francodex

6.3.11 Merck Animal Health

6.3.12 PetArmor (Tevra)

6.3.13 PetIQ / Sergeant's

6.3.14 Professional Pet Products

6.3.15 Promika (Manna Pro)

6.3.16 Vetoquinol

6.3.17 Virbac

6.3.18 Wellmark International

6.3.19 Wondercide

6.3.20 Zoetis

7 Market Opportunities & Future Outlook

7.1 White-space & Unmet-Need Assessment

For more information about this report visit https://www.researchandmarkets.com/r/2lqe43

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.